title: Synergistically enhanced immunosuppressive effect by combined use of cyclosporine and mizoribine.
authors.affiliation: National Cardiovascular Center, Research Institute, Osaka, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Amemiya
authors.forename: S
authors.initials: S
authors.lastname: Suzuki
authors.forename: H
authors.initials: H
authors.lastname: Watanabe
authors.forename: R
authors.initials: R
authors.lastname: Hayashi
authors.forename: S
authors.initials: S
authors.lastname: Niiya
mesh_terms: D000818:Animals; D003524:Cyclosporins / Q000627:therapeutic use*; D004285:Dogs; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D006085:Graft Survival / Q000187:drug effects*; D016027:Heart Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation; D009206:Myocardium / Q000473:pathology; D012263:Ribonucleosides / Q000627:therapeutic use*; D014184:Transplantation, Homologous / Q000379:methods
chemical_list: D003524:Cyclosporins; D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine